Literature DB >> 23988272

Bi-level multi-source learning for heterogeneous block-wise missing data.

Shuo Xiang1, Lei Yuan1, Wei Fan2, Yalin Wang3, Paul M Thompson4, Jieping Ye5.   

Abstract

Bio-imaging technologies allow scientists to collect large amounts of high-dimensional data from multiple heterogeneous sources for many biomedical applications. In the study of Alzheimer's Disease (AD), neuroimaging data, gene/protein expression data, etc., are often analyzed together to improve predictive power. Joint learning from multiple complementary data sources is advantageous, but feature-pruning and data source selection are critical to learn interpretable models from high-dimensional data. Often, the data collected has block-wise missing entries. In the Alzheimer's Disease Neuroimaging Initiative (ADNI), most subjects have MRI and genetic information, but only half have cerebrospinal fluid (CSF) measures, a different half has FDG-PET; only some have proteomic data. Here we propose how to effectively integrate information from multiple heterogeneous data sources when data is block-wise missing. We present a unified "bi-level" learning model for complete multi-source data, and extend it to incomplete data. Our major contributions are: (1) our proposed models unify feature-level and source-level analysis, including several existing feature learning approaches as special cases; (2) the model for incomplete data avoids imputing missing data and offers superior performance; it generalizes to other applications with block-wise missing data sources; (3) we present efficient optimization algorithms for modeling complete and incomplete data. We comprehensively evaluate the proposed models including all ADNI subjects with at least one of four data types at baseline: MRI, FDG-PET, CSF and proteomics. Our proposed models compare favorably with existing approaches.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Block-wise missing data; Multi-modal fusion; Multi-source; Optimization

Mesh:

Year:  2013        PMID: 23988272      PMCID: PMC3937297          DOI: 10.1016/j.neuroimage.2013.08.015

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  22 in total

1.  Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study.

Authors:  Yong Fan; Susan M Resnick; Xiaoying Wu; Christos Davatzikos
Journal:  Neuroimage       Date:  2008-03-06       Impact factor: 6.556

2.  MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Authors:  P Vemuri; H J Wiste; S D Weigand; L M Shaw; J Q Trojanowski; M W Weiner; D S Knopman; R C Petersen; C R Jack
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

3.  Comparing predictors of conversion and decline in mild cognitive impairment.

Authors:  S M Landau; D Harvey; C M Madison; E M Reiman; N L Foster; P S Aisen; R C Petersen; L M Shaw; J Q Trojanowski; C R Jack; M W Weiner; W J Jagust
Journal:  Neurology       Date:  2010-06-30       Impact factor: 9.910

4.  CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.

Authors:  Anders M Fjell; Kristine B Walhovd; Christine Fennema-Notestine; Linda K McEvoy; Donald J Hagler; Dominic Holland; James B Brewer; Anders M Dale
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

5.  Sparse Methods for Biomedical Data.

Authors:  Jieping Ye; Jun Liu
Journal:  SIGKDD Explor       Date:  2012-06-01

6.  Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population.

Authors:  Chris Hinrichs; Vikas Singh; Guofan Xu; Sterling C Johnson
Journal:  Neuroimage       Date:  2010-12-10       Impact factor: 6.556

7.  Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data.

Authors:  Lei Yuan; Yalin Wang; Paul M Thompson; Vaibhav A Narayan; Jieping Ye
Journal:  Neuroimage       Date:  2012-03-29       Impact factor: 6.556

8.  Multi-modal imaging predicts memory performance in normal aging and cognitive decline.

Authors:  K B Walhovd; A M Fjell; A M Dale; L K McEvoy; J Brewer; D S Karow; D P Salmon; C Fennema-Notestine
Journal:  Neurobiol Aging       Date:  2008-10-05       Impact factor: 4.673

9.  Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Authors:  K B Walhovd; A M Fjell; J Brewer; L K McEvoy; C Fennema-Notestine; D J Hagler; R G Jennings; D Karow; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

10.  A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces cerevisiae).

Authors:  Olga G Troyanskaya; Kara Dolinski; Art B Owen; Russ B Altman; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 12.779

View more
  20 in total

1.  Weakly Supervised Deep Learning for Brain Disease Prognosis Using MRI and Incomplete Clinical Scores.

Authors:  Mingxia Liu; Jun Zhang; Chunfeng Lian; Dinggang Shen
Journal:  IEEE Trans Cybern       Date:  2019-03-26       Impact factor: 11.448

2.  Deep sparse multi-task learning for feature selection in Alzheimer's disease diagnosis.

Authors:  Heung-Il Suk; Seong-Whan Lee; Dinggang Shen
Journal:  Brain Struct Funct       Date:  2015-05-21       Impact factor: 3.270

3.  View-aligned hypergraph learning for Alzheimer's disease diagnosis with incomplete multi-modality data.

Authors:  Mingxia Liu; Jun Zhang; Pew-Thian Yap; Dinggang Shen
Journal:  Med Image Anal       Date:  2016-11-16       Impact factor: 8.545

4.  Diagnosis of Alzheimer's Disease Using View-Aligned Hypergraph Learning with Incomplete Multi-modality Data.

Authors:  Mingxia Liu; Jun Zhang; Pew-Thian Yap; Dinggang Shen
Journal:  Med Image Comput Comput Assist Interv       Date:  2016-10-02

Review 5.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

6.  Extracting patterns of morphometry distinguishing HIV associated neurodegeneration from mild cognitive impairment via group cardinality constrained classification.

Authors:  Yong Zhang; Dongjin Kwon; Pardis Esmaeili-Firidouni; Adolf Pfefferbaum; Edith V Sullivan; Harold Javitz; Victor Valcour; Kilian M Pohl
Journal:  Hum Brain Mapp       Date:  2016-08-04       Impact factor: 5.038

7.  Multi-Source Multi-Target Dictionary Learning for Prediction of Cognitive Decline.

Authors:  Jie Zhang; Qingyang Li; Richard J Caselli; Paul M Thompson; Jieping Ye; Yalin Wang
Journal:  Inf Process Med Imaging       Date:  2017-05-23

Review 8.  Whole-genome analyses of whole-brain data: working within an expanded search space.

Authors:  Sarah E Medland; Neda Jahanshad; Benjamin M Neale; Paul M Thompson
Journal:  Nat Neurosci       Date:  2014-05-27       Impact factor: 24.884

9.  Latent Representation Learning for Alzheimer's Disease Diagnosis With Incomplete Multi-Modality Neuroimaging and Genetic Data.

Authors:  Tao Zhou; Mingxia Liu; Kim-Han Thung; Dinggang Shen
Journal:  IEEE Trans Med Imaging       Date:  2019-04-25       Impact factor: 10.048

Review 10.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.